Murrell Dedee F,Paller Amy S,Bodemer Christine,Browning John,Nikolic Milos MI,Barth Jay A,Lagast Hjalmar,Krusinska Eva,Reha Allen (2020) Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study, ORPHANET JOURNAL OF RARE DISEASES, vol. 15, br. 1, str. - (Article) 

Paller Amy S,Browning John,Nikolic Milos MI,Bodemer Christine,Murrell Dedee F,Lenon Willistine,Krusinska Eva,Reha Allen,Lagast Hjalmar,Barth Jay A (2020) Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study), ORPHANET JOURNAL OF RARE DISEASES, vol. 15, br. 1, str. - (Article) 

Paller Amy S,Browning John,Nikolic Milos MI,Bodemer Christine,Krusinska Eva,Reha Allen,Lagast Hjalmar,Barth Jay A (2018) Results from the phase 3, double-blind, vehicle-controlled ESSENCE trial of the topical investigational drug SD-101 in epidermolysis bullosa, JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 138, br. 5, str. S100-S100 (Meeting Abstract)